Palvella Therapeutics (PVLA) Curent Deferred Tax Liability (2013 - 2015)

Palvella Therapeutics (PVLA) has 3 years of Curent Deferred Tax Liability data on file, last reported at $24464.0 in Q3 2015.

• On a quarterly basis, Curent Deferred Tax Liability changed N/A year-over-year to $24464.0 in Q3 2015; TTM through Sep 2015 was $24464.0, a N/A change from a year earlier, with the FY2014 full-year figure at $26522.0, up 40.5% from the prior year.
• Curent Deferred Tax Liability for Q3 2015 stood at $24464.0, roughly flat from $24446.0 in the prior quarter.
• Over the last five years, Curent Deferred Tax Liability for PVLA reached as high as $26522.0 in Q4 2014 and fell as low as $18877.0 in Q4 2013.
• Historically, Curent Deferred Tax Liability has averaged $23570.0 across 3 years, with a median of $24446.0 in 2015.
• On a YoY basis, Curent Deferred Tax Liability climbed as much as 40.5% in 2014 and fell as far as 40.5% in 2014.
• Year by year, Curent Deferred Tax Liability stood at $18877.0 in 2013, then soared by 40.5% to $26522.0 in 2014, then dropped by 7.76% to $24464.0 in 2015.
• Per Business Quant data, the three most recent Curent Deferred Tax Liability figures were $24464.0 in Q3 2015, $24446.0 in Q2 2015, and $23541.0 in Q1 2015.